Anar Dossumbekova, M.D.

33% more Medicare Part D claims than the average allergy & immunology physician in 2024

1,051 Medicare Part D claims for 124 beneficiaries, against an average of 788 among the 2,397 providers of this specialty who prescribed in Part D. Brand-name drugs were 35% of claims.

Most prescribed

1. Montelukast Sodium138 claims
2. Azelastine Hcl81 claims
3. Fluticasone Propionate67 claims
4. Levocetirizine Dihydrochloride67 claims
5. Dupixent Pen50 claims
6. Trelegy Ellipta48 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's Medicare quality score for 2023: 85.5 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $111.26

5 payments, mostly food and beverage; the largest payer was GlaxoSmithKline, LLC.. The 2,070 providers of this specialty with any payment received $8,602.63 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

One hospital or facility affiliation

1. University OF Penn - Medical GroupPhiladelphia, PA

Source: CMS Doctors and Clinicians affiliations; Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.